Page 52 - ITPS-6-2

INNOSC Theranostics and
Pharmacological Sciences Genotoxicity of (4-fluorophenyl) thiazolidin-4-one

derivatives. Il Farmaco, 57: 747–751. https://doi.org/10.4103/0250-474X.41448
https://doi.org/10.1016/S0014-827X(02)01268-5 29. Kosurkar UB, Mamilla J, Dadmal TL, et al., 2023, Synthesis
of novel Thiazolidine-4-One derivatives, their cytotoxicity,
17. Rao A, Balzarini J, Carbone A, et al., 2004, Synthesis of new
2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents. Il antifungal properties, molecular docking and molecular
Farmaco, 59: 33–39. dynamics. Rus J Bioorg Chem, 49, 314–323.
https://doi.org/10.1134/S1068162023020127
https://doi.org/10.1016/j.farmac.2003.09.001
30. Gandhi B, Juliya J, Dileep V, et al., 2021, Antioxidant and
18. Balzarini J, Orzeszko B, Maurin JK, et al., 2007, Synthesis and
anti-HIV studies of 2-adamantyl-substituted thiazolidin-4- biological activities of novel structured monoacylglycerol
ones. Eur J Med Chem, 42: 993–1003. derivatives with phenolic acids. Eur J Lipid Sci Technol,
123: 2100055.
https://doi.org/10.1016/j.ejmech.2007.01.003
https://doi.org/10.1002/ejlt.202100055
19. Rao A, Chimirri A, Ferro S, et al., 2004, Microwave-induced 31. Deshpande SS, Veeragoni D, Rachamalla HK, et al., 2022,
synthesis of benzimidazole and thiazolidinone derivatives as Anticancer properties of ZnO-Curcumin nanocomposite
HIV-1 RT inhibitors. Arkivoc, 5: 147–155.
against melanoma cancer and its genotoxicity profiling.
https://doi.org/10.3998/ark.5550190.0005.514 J Drug Deliv Sci Tech, 75: 103703.
20. Ravichandran V, Kumar BP, Sankar S, 2009, Predicting anti- https://doi.org/10.1016/j.jddst.2022.103703
HIV activity of 1,3,4-thiazolidinone derivaties: 3D-QSAR
approach. Eur J Med Chem, 44: 1180–1187. 32. Choudante PC, Nethi SK, Díaz-García D, et al., 2022, Tin-
loaded mesoporous silica nanoparticles: Antineoplastic
https://doi.org/10.1016/j.ejmech.2008.05.036 properties and genotoxicity assessment. Biomater Adv,
21. Mosula L, Zimenkovsky B, Havrylyuk D, et al., 2009, 137: 212819.
Synthesis and antitumor activity of novel 2-thioxo-4- https://doi.org/10.1016/j.bioadv.2022.212819
thiazolidinones with benzothiazole moieties. Farmacia, 33. Javvaji K, Mamilla J, Kongari L, et al., 2023, In vitro
57: 321–330.
cytogenetic toxicity and cell cycle arrest profiling of
22. Dua R, Shrivastava S, Sonwane SK, et al., 2011, fluorinated trifluoromethyl 4-Thiazolidinone on CHO-
Pharmacological significance of synthetic heterocycles K1 cells. Arch Clin Toxicol, 5: 1–8.
scaffold: A review. Adv Biol Res, 5: 20–144.
https://doi.org/10.46439/toxicology.5.018
23. Zahradnik M, 1983, The Production and Application of
Fluorescent Brightening Agents. Translated by Wilkinson 34. Bhat M, Poojary B, Kalal BS, et al., 2018, Synthesis and
Procharzka ZF. Chichester: Wiley-Interscience, p147. evaluation of thiazolidinone-pyrazole conjugates as
anticancer and antimicrobial agents. Future Med Chem,
24. Naganna MG, Rohini YR, 2014, Synthesis antimicrobial 10: 1017–1036.
and antioxidant evaluation of 3-(2-(4-fluorobenzylthio) https://doi.org/10.4155/fmc-2017-0191
pyrimidin-4-yl-amino)-2-(3-substituted phenyl)
thiazolidin-4-ones. World J Pharm Pharm Sci, 3: 1094–1109. 35. Djukic M, Fesatidou M, Xenikakis I, et al., 2018, In vitro
antioxidant activity of thiazolidinone derivatives of
25. Liu HL, Li Z, Anthonsen T, 2000, Synthesis and fungicidal 1,3-thiazole and 1,3,4-thiadiazole. Chem Biol Interact,
activity of 2-imino-3-(4-arylthiazol-2-yl)-thiazolidin-4-ones
and their 5-arylidene derivatives. Molecules, 5: 1055–1061. 286: 119–131.
https://doi.org/10.1016/j.cbi.2018.03.013
https://doi.org/10.3390/50901055
36. Dillehay LE, Denstman SC, Williams JR, 1987, Cell cycle
26. Radin NS, 2008, Drug design: Hiding in full view. Drug Dev dependence of sister chromatid exchange induction by DNA
Res, 69: 15–25.
topoisomerase II inhibitors in Chinese hamster V79 cells.
https://doi.org/10.1002/ddr.20223 Can Res, 47: 206–209.
27. Thomas AB, Nanda RK, Kothapalli LP, et al., 2013, Synthesis, 37. Çelik A, Eke D, 2011, The assessment of cytotoxicity and
biological activity, molecular modelling studies and genotoxicity of tetracycline antibiotic in human blood
3D-QSAR Investigations of N-[2-(aryl/substituted aryl)-4- lymphocytes using CBMN and SCE analysis, in vitro. Int J
oxo-1, 3-thiazolidin-3-yl] pyridine-4-carboxamides. Open Hum Gen, 11: 23–29.
Conf Proc J, 4: 99–112.
https://doi.org/10.1080/09723757.2011.11886119
https://doi.org/10.2174/2210289201304010099
38. Hagmar L, Bonassi S, Strömberg U, et al., 1998, Chromosomal
28. Taranalli AD, Bhat AR, Srinivas S, et al., 2008, aberrations in lymphocytes predict human cancer: A report
Antiinflammatory,analgesic and antipyretic activity of from the European Study Group on Cytogenetic Biomarkers
certain thiazolidinones. Indian J Pharm Sci, 70: 159. and Health (ESCH). Can Res, 58: 4117–4121.

Volume 6 Issue 2 (2023) 9 https://doi.org/10.36922/itps.0618